Commercialization

WestVac BioPharma Co., Ltd. is an innovative biopharmaceutical enterprise integrating vaccine R&D, production and sales, including WestVac Biopharma located in Chengdu and WestVac Biopharma (Guangzhou), a wholly-owned subsidiary company of WestVac Biopharma. WestVac Biopharma Co., Ltd. is located in in Chengdu Tianfu International Biological City,relying on mature insect cell expression platform, novel adjuvant platform, bacterial vaccine platform, mRNA vaccine platform, tumor vaccine and immunotherapy platform, devoting to research, develop and produce a variety of innovative vaccines and immunotherapy products.

WestVac Biopharma Co., Ltd. is located in in Chengdu Tianfu International Biological City.It has completed construction of 5,000-litre and 3,000-litre insect cell recombinant protein vaccine production lines with an annual production capacity of 100 million doses. The GMP production lines were well established with the “Drug Production License" in place in September, 2021. WestVac Biopharma has received the GMP (Good Manufacturing Practice) certificate from the Federal Commission for Protection against Sanitary Risks (COFEPRIS) in Mexico in January, 2024, a member of the Pharmaceutical Inspection Co-operation Scheme (PIC/S). This certification covers all the COVID-19 vaccines produced by WestVac Biopharma using insect cells (Sf9), including the Recombinant COVID-19 Trivalent (XBB.1.5+BA.5+Delta) Protein Vaccine (Sf9 Cell) and other COVID-19 vaccine series. WestVac Biopharma (Guangzhou) is located in Guangzhou Economic Development Zone. It has completed scale-up construction of insect cell recombinant protein vaccine production lines with an annual production capacity of 100 million doses, and obtained the “Drug Production License" in February, 2024. 

In terms of production, quality, operations management and other areas, WestVac Biopharma has introduced top talents from well-known Chinese and international vaccine companies. It has also established a complete production and quality management system to ensure a smooth mass production of vaccines.

WestVac Biopharma has established a sound communication mechanism with many international organizations such as the World Health Organization (WHO), Bill & Melinda Gates Foundation, PATH, The Coalition for Epidemic Preparedness Innovations (CEPI), and European Vaccine Initiative (EVI). 

In the future, WestVac Biopharma will grow into a world leading vaccine and immunotherapy platform in line with its corporate philosophy of "We Initiate Science & Technology Value, Always for Caring". Westvac extensively explores and innovates to prevent and fight human diseases. Westvac brings innovative vaccines and immunotherapies from China to the world for the benefit of mankind.